| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/14/2002 | US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 05/14/2002 | US6387932 Somatostatin agonists |
| 05/14/2002 | US6387925 Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387899 Antiserotonine agents; antidepressants |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387897 Preferentially substituted calcium channel blockers |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387891 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387434 Powder products of ginkgo leaves and their manufacturing process |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387365 Alpha interferon and ribavirin where the amount of alpha interferon is less than 3 million iu weekly, qod or daily; alpha interferon is interferon alpha2; reduction of side effects |
| 05/14/2002 | US6387352 Phosphate containing solution and calcium containing solution which when combined form a supersaturated calcium phosphate rinse for treating and preventing oral disease of soft tissues and for remineralization of hard tissues |
| 05/14/2002 | CA2260898C Phosphinate based inhibitors of matrix metalloproteases |
| 05/14/2002 | CA2249666C Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 05/14/2002 | CA2247105C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic di seases |
| 05/14/2002 | CA2060815C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochr omanes |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036593A1 Indole derivatives as pde5-inhibitors |
| 05/10/2002 | WO2002036576A1 Phthalazinone derivatives |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 05/10/2002 | WO2002036558A2 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| 05/10/2002 | WO2002036552A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 05/10/2002 | WO2002036551A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 05/10/2002 | WO2002036156A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/10/2002 | WO2002036151A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | WO2002036137A1 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 05/10/2002 | WO2002036122A1 Preventive or therapeutic medicines for hepatitis and/or hepatopathy |
| 05/10/2002 | WO2002036118A2 Heterocyclic derivatives useful as pharmaceutical agents |
| 05/10/2002 | WO2002036116A2 Tripeptidyl peptidase inhibitors |
| 05/10/2002 | WO2002036115A1 Sulphonamides for the treatment of central nervous system diseases |
| 05/10/2002 | WO2002036098A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 05/10/2002 | WO2002036072A2 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001068135A3 Compositions and methods for affecting osteogenesis |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001064214A3 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 05/10/2002 | WO2001038326A3 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/10/2002 | WO2001037784A3 Method for preventing irinotecan induced diarrhea |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001034600A9 Protease inhibitors |
| 05/10/2002 | WO2001034599A9 Protease inhibitors |
| 05/10/2002 | WO2001034157A9 Protease inhibitors |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/10/2002 | WO2001027135A3 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | WO2001005388A3 Use of a fatty derivative for the treatment of external secretiondisorders |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | CA2427537A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/10/2002 | CA2427533A1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427194A1 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | CA2426977A1 Sulphonamides for the treatment of central nervous system diseases |
| 05/10/2002 | CA2426026A1 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| 05/10/2002 | CA2395324A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | WO2002036153A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | US20020055635 Cycloalkano-indole and -azaindole derivatives |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055495 Two-component anti-emetic composition |
| 05/09/2002 | US20020055483 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055471 Purification step using a brominated polystyrene resin to adsorb anthocyanins |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020054880 Suppressing inflammatory response in mammal by the administration of lectin derived carbohydrate binding peptide capable of binding terminally linked alpha-sialic acid derivative |
| 05/09/2002 | US20020054868 Bacterial strain, processes plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020054867 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 05/09/2002 | US20020054866 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020054859 A mixture of olive and parsley oils useful for treatment of halitosis or bad breath |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity |
| 05/08/2002 | EP1203586A2 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin. |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202996A1 Titanium derived compounds, preparation and use thereof |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202989A1 Benzamide derivatives |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202969A2 Biphenyl derivatives, production thereof and use as medicines |
| 05/08/2002 | EP1202967A2 Sulfuric acid mono-[3-((1-(2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl)-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |